Dr. Nowak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Howard Ave Lowr Level
Yale School of Medicine Department of Neurology
New Haven, CT 06519Phone+1 203-785-4085
Education & Training
Yale-New Haven Medical CenterFellowship, Neuromuscular Medicine (Neurology), 2011 - 2012- Yale-New Haven Medical CenterResidency, Neurology, 2008 - 2011
- Yale-New Haven Medical CenterInternship, Internal Medicine, 2007 - 2008
Drexel University College of MedicineClass of 2007
Certifications & Licensure
CT State Medical License 2012 - 2025- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- International Guillain-Barré Syndrome Outcome Study Start of enrollment: 2012 May 01
- BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis Start of enrollment: 2014 May 01
- A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis Start of enrollment: 2015 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Fluorescence-detection size-exclusion chromatography specifically detects autoantibodies targeting the ganglionic acetylcholine receptor in patients with autoimmune au...Leah Baxter, Steven Hopkins, Kevin C O'Connor, Minh C Pham, Richard J Nowak
Journal of Neuroimmunology. 2024-11-15 - 1 citationsUnited States clinical practice experience with eculizumab in myasthenia gravis: symptoms, function, and immunosuppressant therapy use.Ali A Habib, Andrew J Klink, Srikanth Muppidi, Anju Parthan, S Chloe Sader
Journal of Neurology. 2024-09-01 - 8 citationsUnveiling the proteome-wide autoreactome enables enhanced evaluation of emerging CAR T cell therapies in autoimmunity.Aaron Bodansky, David Jl Yu, Alysa Rallistan, Muge Kalaycioglu, Jim Boonyaratanakornkit
The Journal of Clinical Investigation. 2024-05-16
Journal Articles
- Clinical Reasoning: Progressive proximal weakness in a 56-year-old man with bone pain.Tara Torabi, Anita Huttner, Richard J. Nowak, Bhaskar Roy, Neurology.org, 11/18/2019
- Autoantibodies Against Neurologic Antigens in Nonneurologic AutoimmunityJane H Buckner, David A Hafler, Richard J Nowak, The Journal of Immunology
Press Mentions
First-in-Class B-cell Depleting Agent Promising for Myasthenia GravisOctober 17th, 2024- What Neurologists Should Know About the 3 COVID-19 VaccinesDecember 10th, 2020
- Myasthenia Gravis: New Drugs and a Road to Individualized TreatmentNovember 22nd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
